Todos Medical Releases Letter to Shareholders
07. Februar 2020 09:15 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos To Present At Upcoming 12th Annual LD Micro Main Event
06. Dezember 2019 07:29 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET
14. November 2019 11:02 ET
|
Todos Medical Ltd.
Topline results expected before the end of Q1/2020 REHOVOT, Israel and NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company...
Todos Medical Appoints Dr. Jorge Leon as Medical Advisor
06. August 2019 07:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Announces Positive Alzheimer's Biomarker Clinical Data from LymPro vs. Amyloid PET Interim Analysis
15. Juli 2019 07:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, July 15, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostic company focused on the development of blood tests for the early...
Todos Medical to Appoint Dr. Paula Trzepacz As Chief Medical Officer And Files New Patent Application
12. Juli 2019 11:05 ET
|
Todos Medical Ltd.
Joint venture Breakthrough Diagnostics files new patent application covering Alzheimer’s blood diagnostic LymPro Test clinical correlation with amyloid PET imagingPreliminary Data on LymPro vs....
Todos Medical to Sponsor the Investacure ‘Cure Coin Awards Reception’ for Alzheimer’s and CTE Research at AAIC 2019 in Los Angeles
27. Juni 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, June 27, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Announces Positive Clinical Trial Data for Breast Cancer Blood Test TM-B1 in Dense Breasts
03. Juni 2019 08:00 ET
|
Todos Medical Ltd.
TM-B1 demonstrates 80% accuracy vs. 50% accuracy for current gold standardTodos Medical to attend 2019 ASCO Annual Meeting in Chicago, IL REHOVOT, Israel, June 03, 2019 (GLOBE NEWSWIRE) -- Todos...
Todos Medical Exercises Option to Acquire Remaining 80.01% of Breakthrough Diagnostics from Amarantus After Review of Alzheimer's Blood Test Data
28. Mai 2019 08:57 ET
|
Todos Medical Ltd.
- Data demonstrated strong correlation between LymPro and amyloid PET- Todos to present at Alzheimer’s Solutions Conference on June 3, 2019 in Philadelphia- Todos to present at LD Micro on June 4th,...
Todos Medical Receives Approval from Israeli Ministry of Health (AMAR) to Market and Sell its Breast Cancer Screens in Israel
23. Mai 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...